Fusion of HepG2 cells with mesenchymal stem cells increases cancer‑associated and malignant properties: An in vivo metastasis model

Li,Hong; Feng,Zhenqing; Tsang,Tom  C.; Tang,Tian; Jia,Xiaoqin; He,Xianghui; Pennington,Michael  E.; Badowski,Michael  S.; Liu,Anna  K.M.; Chen,Deyu; Harris,David  T.; Martinez,Jesse; Meade-Tollin,Linda  C.

doi:10.3892/or.2014.3264

August-2014 Volume 32 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

August-2014 Volume 32 Issue 2

Full Size Image

Article

Fusion of HepG2 cells with mesenchymal stem cells increases cancer‑associated and malignant properties: An in vivo metastasis model

Authors:
- Hong Li
- Zhenqing Feng
- Tom C. Tsang
- Tian Tang
- Xiaoqin Jia
- Xianghui He
- Michael E. Pennington
- Michael S. Badowski
- Anna K.M. Liu
- Deyu Chen
- David T. Harris
- Jesse Martinez
- Linda C. Meade-Tollin
View Affiliations / Copyright

Affiliations: Department of Pathology, Binzhou Medical University Hospital, Binzhou 256603, P.R. China, Key Laboratory of Antibody Technique of the Ministry of Health, Department of Pathology, Nanjing Medical University, Nanjing 210029, P.R. China, Department of General Surgery, Tianjin General Surgery Institute, General Hospital of Tianjin Medical University, Tianjin 300052, P.R. China, Cure Cancer Worldwide Corporation, Tucson, AZ 85728-5833, USA, Department of Immunobiology, University of Arizona, Tucson, AZ 85724, USA, Department of Oncology, The Affiliated Hospital of Jiangsu University, Zhenjiang, Jiangsu 212001, P.R. China, Arizona Cancer Center, University of Arizona, Tucson, AZ 85721, USA
Pages: 539-547
|
Published online on: June 13, 2014

https://doi.org/10.3892/or.2014.3264
Expand metrics +

Abstract

In the present study, we have tested the hypothesis that fusion between an altered cell and a mesenchymal stem cell produces a hybrid cell with enhanced characteristics associated with metastatic cancer cells, and we have developed a flexible model for investigating the mechanisms of metastasis. Human HepG2 cells with low metastatic potential were induced to fuse with rat bone marrow mesenchymal stem cells, and the progeny were compared with the parental cells for possession of enhanced in vitro and in vivo characteristics of malignant cells. Compared to the parental cells, the fused cells exhibited enhanced expression of E-cadherin, vimentin, Twist, Snail, matrix metalloproteinase 2 and 9 activities, aneuploidy and enhanced in vitro invasion and migration. In an in vivo xenograft assay, the fused cells generated increased numbers of metastatic liver and lung lesions. This model system is a flexible tool for investigation of the mechanisms of stem cell fusion in carcinogenesis and metastasis and for the discovery of new therapeutic targets to inhibit metastasis.

View Figures

View References

1	Cairns J: Cancer, Science and Society. Freeman; San Francisco: 1978
2	Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
3	Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC and Clarke SJ: The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 88:218–230. 2013. View Article : Google Scholar : PubMed/NCBI
4	Casazza A, Di Conza G, Wenes M, Finisguerra V, Deschoemaeker S and Mazzone M: Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment. Oncogene. Apr 22–2013.(Epub ahead of print). View Article : Google Scholar
5	De Wever O, Demetter P, Mareel M and Bracke M: Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer. 123:2229–2238. 2008.PubMed/NCBI
6	Mishra PJ, Mishra PJ, Glod JW and Banerjee D: Mesenchymal stem cells: flip side of the coin. Cancer Res. 69:1255–1258. 2009. View Article : Google Scholar : PubMed/NCBI
7	Hass R and Otte A: Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment. Cell Commun Signal. 10:262012. View Article : Google Scholar : PubMed/NCBI
8	He X, Tsang TC, Pipes BL, Ablin RJ and Harris DT: A stem cell fusion model of carcinogenesis. J Exp Ther Oncol. 5:101–109. 2005.PubMed/NCBI
9	Ding J, Jin W, Chen C, Shao Z and Wu J: Tumor associated macrophage x cancer cell hybrids may acquire cancer stem cell properties in breast cancer. PLoS One. 7:e419422012. View Article : Google Scholar : PubMed/NCBI
10	Lu X and Kang Y: Cell fusion as a hidden force in tumor progression. Cancer Res. 69:8536–8539. 2009. View Article : Google Scholar : PubMed/NCBI
11	Lu X and Kang Y: Cell fusion hypothesis of the cancer stem cell. Adv Exp Med Biol. 714:129–140. 2011. View Article : Google Scholar : PubMed/NCBI
12	Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J and Teris AJ: Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer. 5:899–904. 2005. View Article : Google Scholar : PubMed/NCBI
13	Pawelek JM and Chakraborty AK: Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer. 8:377–386. 2008. View Article : Google Scholar : PubMed/NCBI
14	Soleimani M and Nadri S: A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc. 4:102–106. 2009. View Article : Google Scholar : PubMed/NCBI
15	Köhler G and Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:495–497. 1975.
16	Yang MH, Chang SY, Chiou SH, Liu CJ, Chi CW, Chen PM, et al: Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer. Oncogene. 26:1459–1467. 2007. View Article : Google Scholar : PubMed/NCBI
17	Duelli D and Lazebnik Y: Cell fusion: a hidden enemy? Cancer Cell. 3:445–448. 2003. View Article : Google Scholar : PubMed/NCBI
18	Gerling M, Nousiainen K, Hautaniemi S, Krüger S, Fritzsche B, Homann N, et al: Aneuploidy-associated gene expression signatures characterize malignant transformation in ulcerative colitis. Inflamm Bowel Dis. 19:691–703. 2013. View Article : Google Scholar : PubMed/NCBI
19	Luzzo KM, Wang Q, Purcell SH, Chi M, Jimenez PT, Grindler N, et al: High fat diet induced developmental defects in the mouse: oocyte meiotic aneuploidy and fetal growth retardation/brain defects. PLoS One. 7:e492172012. View Article : Google Scholar : PubMed/NCBI
20	Hanna MO, Zayed NA, Darwish H and Girgis SI: Asynchronous DNA replication and aneuploidy in lymphocytes of hepatocellular carcinoma patients. Cancer Genet. 205:636–643. 2012. View Article : Google Scholar : PubMed/NCBI
21	Pfau SJ and Amon A: Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep. 13:515–527. 2012. View Article : Google Scholar : PubMed/NCBI
22	Stein-Werblowsky R and Ablin RJ: Consideration of the possible etiology of prostatic cancer. II International Congress of Andrology, Tel Aviv, Israel. Israel J Med Sci. 17:abs. 743. 1981.
23	Fan F, Samuel S, Evans KW, Lu J, Xia L, Zhou Y, et al: Overexpression of Snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells. Cancer Med. 1:5–16. 2012. View Article : Google Scholar : PubMed/NCBI
24	Gavert N and Ben-Ze’ev A: Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med. 14:199–209. 2008. View Article : Google Scholar : PubMed/NCBI
25	Horikawa T, Yoshizaki T, Kondo S, Furukawa M, Kaizaki Y and Pagano JS: Epstein-Barr virus latent membrane protein 1 induces Snail and epithelial-mesenchymal transition in metastatic nasopharyngeal carcinoma. Br J Cancer. 104:1160–1167. 2011. View Article : Google Scholar
26	Jordà M, Olmeda D, Vinyals A, Valero E, Cubillo E, Llorens A, et al: Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. J Cell Sci. 118:3371–3385. 2005.PubMed/NCBI
27	Parsons JT, Zetter B and Mohla S: Shifting paradigms in tumor metastasis: challenges and opportunities. Cancer Biol Ther. 1:582–585. 2002. View Article : Google Scholar : PubMed/NCBI
28	Goldstein RH, Weinberg RA and Rosenblatt M: Of mice and (wo)men: mouse models of breast cancer metastasis to bone. J Bone Miner Res. 25:431–436. 2010. View Article : Google Scholar : PubMed/NCBI
29	Sasai K, Sukezane T, Yanagita E, Nakagawa H, Hotta A, Itoh T and Akagi T: Oncogene-mediated human lung epithelial cell transformation produces adenocarcinoma phenotypes in vivo. Cancer Res. 71:2541–2549. 2011. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Fusion of HepG2 cells with mesenchymal stem cells increases cancer‑associated and malignant properties: An in vivo metastasis model

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Related Articles